ranolazine has been researched along with Diabetic Angiopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaitman, BR; Crager, M; Timmis, AD | 1 |
| Cooper-DeHoff, R; Pepine, CJ | 1 |
| Belardinelli, L; Braunwald, E; Gersh, BJ; Hedgepeth, CM; Hod, H; McCabe, CH; Molhoek, P; Morrow, DA; Murphy, SA; Scirica, BM; Verheugt, FW | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
2 trial(s) available for ranolazine and Diabetic Angiopathies
| Article | Year |
|---|---|
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.
Topics: Acetanilides; Aged; Angina Pectoris; Chronic Disease; Diabetic Angiopathies; Double-Blind Method; Enzyme Inhibitors; Exercise Tolerance; Female; Glycated Hemoglobin; Humans; Male; Nitroglycerin; Piperazines; Ranolazine; Treatment Outcome; Vasodilator Agents | 2006 |
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischem
Topics: Acetanilides; Acute Disease; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Diabetic Angiopathies; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Placebos; Ranolazine; Tachycardia; Thrombolytic Therapy | 2007 |
2 other study(ies) available for ranolazine and Diabetic Angiopathies
| Article | Year |
|---|---|
Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.
Topics: Acetanilides; Angina Pectoris; Cardiotonic Agents; Diabetic Angiopathies; Exercise Tolerance; Humans; Piperazines; Ranolazine | 2006 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |